Supporting Aboriginal Community Controlled Health Services to deliver alcohol care: protocol for a cluster randomised controlled trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 11 2019
Historique:
entrez: 13 11 2019
pubmed: 13 11 2019
medline: 27 10 2020
Statut: epublish

Résumé

Indigenous peoples who have experienced colonisation or oppression can have a higher prevalence of alcohol-related harms. In Australia, Aboriginal Community Controlled Health Services (ACCHSs) offer culturally accessible care to Aboriginal and Torres Strait Islander (Indigenous) peoples. However there are many competing health, socioeconomic and cultural client needs. A randomised cluster wait-control trial will test the effectiveness of a model of tailored and collaborative support for ACCHSs in increasing use of alcohol screening (with Alcohol Use Disorders Identification Test-Consumption (AUDIT-C)) and of treatment provision (brief intervention, counselling or relapse prevention medicines). Twenty-two ACCHSs across Australia. Services will be stratified by remoteness, then randomised into two groups. Half receive support soon after the trial starts (intervention or 'early support'); half receive support 2 years later (wait-control or 'late support'). Core support elements will be tailored to local needs and include: support to nominate two staff as champions for increasing alcohol care; a national training workshop and bimonthly teleconferences for service champions to share knowledge; onsite training, and bimonthly feedback on routinely collected data on screening and treatment provision. Primary outcome is use of screening using AUDIT-C as routinely recorded on practice software. Secondary outcomes are recording of brief intervention, counselling, relapse prevention medicines; and blood pressure, gamma glutamyltransferase and HbA1c. Multi-level logistic regression will be used to test the effectiveness of support. Ethical approval has been obtained from eight ethics committees: the Aboriginal Health and Medical Research Council of New South Wales (1217/16); Central Australian Human Research Ethics Committee (CA-17-2842); Northern Territory Department of Health and Menzies School of Health Research (2017-2737); Central Queensland Hospital and Health Service (17/QCQ/9); Far North Queensland (17/QCH/45-1143); Aboriginal Health Research Ethics Committee, South Australia (04-16-694); St Vincent's Hospital (Melbourne) Human Research Ethics Committee (LRR 036/17); and Western Australian Aboriginal Health Ethics Committee (779). ACTRN12618001892202; Pre-results.

Identifiants

pubmed: 31712335
pii: bmjopen-2019-030909
doi: 10.1136/bmjopen-2019-030909
pmc: PMC6858116
doi:

Banques de données

ANZCTR
['ACTRN12618001892202']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e030909

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Alcohol Alcohol. 2016 Sep;51(5):515-21
pubmed: 27337988
Lancet. 2017 Sep 16;390(10100):1345-1422
pubmed: 28919119
Br Med J (Clin Res Ed). 1986 Sep 20;293(6549):735-7
pubmed: 3094634
Med J Aust. 2008 May 5;188(9):525-6
pubmed: 18459924
Aust Health Rev. 2018 Apr;42(2):218-226
pubmed: 28263705
Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148
pubmed: 29476653
Drug Alcohol Rev. 2013 Jan;32(1):72-9
pubmed: 22775591
Addiction. 2003 Dec;98 Suppl 2:31-43
pubmed: 14984240
Med J Aust. 2002 Mar 18;176(6):273-6
pubmed: 11999260
Addict Sci Clin Pract. 2018 Mar 29;13(1):5
pubmed: 29592801
Aust N Z J Public Health. 2010 Feb;34(1):38-44
pubmed: 20920103
Drug Alcohol Rev. 2006 May;25(3):277-87
pubmed: 16753652
Int J Qual Health Care. 2009 Feb;21(1):37-43
pubmed: 18988656
Drug Alcohol Rev. 2003 Mar;22(1):53-9
pubmed: 12745359
J Subst Abuse Treat. 2017 Nov;82:107-112
pubmed: 29021108
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
Addict Sci Clin Pract. 2017 May 10;12(1):14
pubmed: 28490342
Drug Alcohol Rev. 2014 Sep;33(5):482-90
pubmed: 24684618
Med J Aust. 2007 Oct 15;187(8):453-7
pubmed: 17937642
BMC Health Serv Res. 2009 Jul 03;9:114
pubmed: 19575791
Drug Alcohol Depend. 2016 Sep 01;166:254-7
pubmed: 27394934
Trials. 2012 Aug 25;13:149
pubmed: 22920408
Addict Sci Clin Pract. 2014 Sep 01;9:17
pubmed: 25179547
J Stud Alcohol Drugs. 2013 Jul;74(4):598-604
pubmed: 23739024
Am J Prev Med. 2008 Feb;34(2):143-152
pubmed: 18201645
Drug Alcohol Rev. 2012 Jan;31(1):13-9
pubmed: 21426422
Drug Alcohol Depend. 2015 Feb 1;147:116-21
pubmed: 25533894
Can J Psychiatry. 2000 Sep;45(7):607-16
pubmed: 11056823
Addiction. 2015 Dec;110(12):1877-900
pubmed: 26234486

Auteurs

Kristie H Harrison (KH)

Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2006.

Ks Kylie Lee (KK)

Discpline of Addiction Medicine, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
Centre for Alcohol Policy Research, La Trobe University, Melbourne, Victoria, Australia.

Timothy Dobbins (T)

School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Scott Wilson (S)

Discpline of Addiction Medicine, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
Aboriginal Drug and Alcohol Council of South Australia, Underdale, South Australia, Australia.

Noel Hayman (N)

Southern Queensland Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care (Inala Indigenous Health Service), Inala, Queensland, Australia.
School of Medicine, Griffith University, Nathan, Queensland, Australia.

Rowena Ivers (R)

Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, NSW, 2006.
Illawarra Aboriginal Medical Service, Wollongong, New South Wales, Australia.

Paul S Haber (PS)

Discpline of Addiction Medicine, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.
Drug Health Services, Sydney Local Health District, Camperdown, New South Wales, Australia.

James H Conigrave (JH)

Discpline of Addiction Medicine, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia.

David Johnson (D)

Aboriginal Health Council of South Australia, Adelaide, South Australia, Australia.

Beth Hummerston (B)

Aboriginal Health Council of South Australia, Adelaide, South Australia, Australia.

Dennis Gray (D)

National Drug Research Institute, Curtin University Bentley Campus, Perth, Western Australia, Australia.

Katherine Conigrave (K)

Discpline of Addiction Medicine, Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, New South Wales, Australia kate.conigrave@sydney.edu.au.
Drug Health Services, Sydney Local Health District, Camperdown, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH